Skip To Main Content
Nuria Barquero on Muck Rack

Nuria Barquero

As seen in: The American Journal of Human Genetics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nuria

Contact Nuria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1

|
By Irene González-Martínez, Estefania Cerro-Herreros, Marc Carrascosa-Saez, Andrea García-Rey, Diego Piqueras-Losilla, Anna Colom-Rodrigo, Nerea Moreno, Mouli Chakraborty, Aline Huguet-Lachon, Anchel González-Barriga, Neia Naldaiz-Gastesi, Martxel Dehesa, Ana Díaz-Maqueda, Nuria Barquero, Miguel Varela Verified, Ramon Eritja, Genevieve Gourdon, Arturo López-Castel, Manuel Pérez-Alonso, Beatriz Llamusi, Rubén Artero, Adolfo López de Munain
| The American Journal of Human Genetics Verified
Keywords antisense oligonucleotides MBNL myotonic dystrophy oleic acid conjugate muscle uptake Introduction Myotonic dystrophy type 1 (DM1; MIM: 160900) is a rare genetic disorder with an overall prevalence of one in 3,000–8,000 individuals worldwide.1 DM1 is characterized by expansion of an unstable CTG microsatellite repeat in the 3′ untranslated region (UTR) of DM1 protein kinase (DMPK; MIM: 605377).
Open in Who Shared Issue with article?
See all 1 articles